Gifu, Japan

Shoei Furukawa

USPTO Granted Patents = 3 

 

Average Co-Inventor Count = 3.3

ph-index = 2

Forward Citations = 8(Granted Patents)


Company Filing History:


Years Active: 2013-2016

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: **Innovator in Pharmaceutical Advancements: The Contributions of Shoei Furukawa**

Introduction

Shoei Furukawa, an inventor based in Gifu, Japan, has made notable contributions to the field of pharmaceuticals, holding a total of three patents. His work has significantly impacted the development of therapeutic agents, particularly for neurological disorders.

Latest Patents

Furukawa's latest inventions include a novel trans-2-decenoic acid derivative and a pharmaceutical agent containing the same. This invention revolves around a specific compound that embodies a trans-2-decenoic acid derivative or a pharmaceutically acceptable salt thereof. The compound is represented by a general formula that includes various substituents, such as a 1-pyrrolidyl or a piperidino group. The utility of this compound is profound, as it serves as a prophylactic or therapeutic agent for a range of conditions including peripheral nerve disorders caused by anticancer treatments, neurodegenerative diseases, mental health issues, as well as spinal cord injuries and various types of pain.

Another aspect of Furukawa's latest patent addresses the safe neurotrophic factor-like activity of the derived compound. This invention aims to provide a pharmaceutical agent that alleviates side effects associated with anticancer drugs, thus demonstrating high therapeutic potential.

Career Highlights

Throughout his career, Shoei Furukawa has worked with esteemed institutions such as the Nagoya Industrial Science Research Institute and Nippon Zoki Pharmaceutical Co., Ltd. His dedication to research in the pharmaceutical field has earned him recognition and respect among his peers.

Collaborations

Furukawa has collaborated with noteworthy individuals in his field, including Munekazu Iinuma and Mitsuru Naiki. These partnerships have contributed to the successful development of his innovative pharmacological compounds and further advancements in research.

Conclusion

Shoei Furukawa's inventions reflect a commitment to enhancing medical treatments and improving patient outcomes. His groundbreaking work on trans-2-decenoic acid derivatives underlines the significance of innovation in addressing complex health challenges. With three patents to his name, Furukawa continues to be a vital asset in the pharmaceutical industry, driving forward the science of medicine.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…